about
AAV-CRISPR/Cas9-Mediated Depletion of VEGFR2 Blocks Angiogenesis In Vitro.In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease.Potential of Gene Editing and Induced Pluripotent Stem Cells (iPSCs) in Treatment of Retinal Diseases.Enhancing Understanding of the Visual Cycle by Applying CRISPR/Cas9 Gene Editing in Zebrafish.CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration.In Vivo Applications of CRISPR-Based Genome Editing in the Retina.CRISPR/Cas9 genome surgery for retinal diseases
P2860
Q47117976-4FBA8842-E237-440C-B8D9-7354D5312AE4Q47553772-B373FF1C-1638-4E94-A12B-769B0D10B01FQ52429677-C8A5105A-00EC-4D5E-BFDD-4C1CA94C5E70Q52431883-BE93F243-7866-4A53-82AF-A1BE6447ED22Q54941286-0889BDD3-FF93-4B2E-AF76-B2F6FE10007FQ55262727-9B851C7B-DF3F-4040-A3FF-2462705282F5Q57171979-D69346F1-5F1B-4EF1-8A75-8238107D61A8
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Genome editing abrogates angiogenesis in vivo.
@en
type
label
Genome editing abrogates angiogenesis in vivo.
@en
prefLabel
Genome editing abrogates angiogenesis in vivo.
@en
P2093
P2860
P1476
Genome editing abrogates angiogenesis in vivo.
@en
P2093
Feng Zhang
Guohong Zhou
Hetian Lei
Jingyuan Song
Luk Vandenberghe
Patricia A D'Amore
Xionggao Huang
P2860
P2888
P356
10.1038/S41467-017-00140-3
P407
P577
2017-07-24T00:00:00Z
P6179
1090754857